{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:10:56Z","timestamp":1789103456151,"version":"build-2803163510"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Women's adherence to the United States (U.S.) Preventive Services Task Force guidelines for cervical cancer screening was determined by examining predisposing, enabling, and needs factors from Andersen's Behavioral Model of Health Services Use conceptual framework.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The outcome was operationalized as cervical cancer screening use, non-use, and inadequate-use. Multinomial logistic regression was conducted on data from the 2019 National Health Interview Survey of 7,331 eligible women aged 21\u201365.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Compared with women who used cervical cancer screening services, women aged 30\u201365 were less likely to be Non-Users than those aged 21\u201329. Hispanic, Asian, and American Indian\/Alaska Native (AIAN) women were more likely to be Non-Users than White women. More educated women were less likely to be Non-Users. Foreign-born women &amp;lt;10 years in the U.S. were more likely to be Non-Users than U.S.-born women. Women with financial hardship were less likely to be Non-Users. Poorer women and uninsured women were more likely to be Non-Users. Women with children in their household were less likely to be Non-Users than those without children. Women who had a well-visit in the past year were less likely to be Non-Users. Women with a history of human papillomavirus (HPV) vaccination were less likely to be Non-Users. Compared with women who used cervical cancer screening services, women aged 30\u201365 were less likely to be Inadequate-Users. AIAN women were more likely to be Inadequate-Users. Women of other races were less likely to be Inadequate-Users. Employed women were less likely to be Inadequate-Users. Uninsured women were more likely to be Inadequate-Users. Women who had a well-visit within a year were less likely to be Inadequate-Users. Women with past HPV vaccination were more likely to be Inadequate-Users. Smokers were less likely to be Inadequate-Users.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Predisposing, enabling, and needs factors are differently associated with non-use and inadequate use of cervical cancer screening. Understanding factors associated with the use, non-use, and inadequate use of cervical cancer screening is crucial to avoid or curb unnecessary tests, increased costs to both society and individuals, and the ill-allocation of limited resources.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2024.1321253","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T04:41:20Z","timestamp":1713760880000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Non-use and inadequate use of cervical cancer screening among a representative sample of women in the United States"],"prefix":"10.3389","volume":"12","author":[{"given":"Marie-Rachelle","family":"Narcisse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearl A.","family":"McElfish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Hallgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Pierre-Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly C.","family":"Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"key":"B1","unstructured":"Cancer Stat Facts: Cervical Cancer: Surveillance, Epidemiology, and End Results Program"},{"key":"B2","unstructured":"Basic Information about HPV and Cancer.2022"},{"key":"B3","doi-asserted-by":"publisher","first-page":"286.e1","DOI":"10.1016\/j.ajog.2020.08.039","article-title":"Cost of care for the initial management of cervical cancer in women with commercial insurance","volume":"224","author":"Blanco","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"B4","unstructured":"Health and Economic Benefits of Cervical Cancer Interventions.2023"},{"key":"B5","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1001\/jama.2018.10400","article-title":"Screening for cervical cancer with high-risk human papillomavirus testing updated evidence report and systematic review for the US preventive services task force","volume":"320","author":"Melnikow","year":"2018","journal-title":"JAMA."},{"key":"B6","unstructured":"Archived: Cervical Cancer: Screening.2012"},{"key":"B7","author":"Vesco","year":"2011","journal-title":"Screening for Cervical Cancer: A Systematic Evidence Review for the U.S. Preventive Services Task Force"},{"key":"B8","doi-asserted-by":"publisher","first-page":"698","DOI":"10.7326\/0003-4819-155-10-201111150-00377","article-title":"Risk factors and other epidemiologic considerations for cervical cancer screening: a narrative review for the US Preventive Services Task Force","volume":"155","author":"Vesco","year":"2011","journal-title":"Ann Intern Med."},{"key":"B9","unstructured":"Recommendation: Cervical Cancer: Screening.2018"},{"key":"B10","unstructured":"HealthyPeople 2030\n          Cervical Cancer: Screening: U.S. Preventive Services Task Force.2018"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13962.","article-title":"Cost-effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India","author":"Arora","year":"2023","journal-title":"Asia Pac J Clin Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/GRF.0b013e3182823797","article-title":"Cost-effectiveness of cervical cancer prevention","volume":"56","author":"Esselen","year":"2013","journal-title":"Clin Obstet Gynecol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"A669","DOI":"10.1016\/j.jval.2013.08.1932","article-title":"Cost-effectiveness analysis of primary and secondary prevention strategies for cervical cancer in Colombia","volume":"16","author":"Gamboa","year":"2013","journal-title":"Value Health"},{"key":"B14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.whi.2022.11.009","article-title":"Coverage for the entire cervical cancer screening process without cost-sharing: lessons from colorectal cancer screening","volume":"33","author":"Ruff","year":"2023","journal-title":"Women Health Issues."},{"key":"B15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/LGT.0000000000000400","article-title":"Excess cost of cervical cancer screening beyond recommended screening ages or after hysterectomy in a single institution","volume":"22","author":"Teoh","year":"2018","journal-title":"J Low Genit Tract Di."},{"key":"B16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.amepre.2014.07.034","article-title":"Demographic factors associated with overuse of pap testing","volume":"47","author":"Kepka","year":"2014","journal-title":"Am J Prev Med."},{"key":"B17","first-page":"482","article-title":"Cervical cancer screening overuse and underuse: patient and physician factors","volume":"19","author":"Almeida","year":"2013","journal-title":"Am J Manag Care."},{"key":"B18","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1001\/jama.2013.107","article-title":"Cervical cancer screening among women aged 18-30 years-United States, 2000-2010 (reprinted from MMWR, vol 51, pg 1038-1042, 2013)","volume":"309","author":"Saraiya","year":"2013","journal-title":"JAMA."},{"key":"B19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1468-0009.2005.00428.x","article-title":"Societal and individual determinants of medical care utilization in the United States","author":"Andersen","year":"2005","journal-title":"Milbank Q"},{"key":"B20","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1186\/s12913-018-3368-3","article-title":"et al. Frequency and predictors of health services use by Native Hawaiians and Pacific Islanders: evidence from the US National Health Interview Survey","volume":"18","author":"Narcisse","year":"2018","journal-title":"BMC Health Serv Res."},{"key":"B21","unstructured":"National Health Interview Survey, 2019 Survey Description2019"},{"key":"B22","article-title":"Stata Statistical Software: Release 17","year":""},{"key":"B23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/CIN.0000000000000610","article-title":"Prevalence of cervical cancer overscreening review of a wellness registry","volume":"38","author":"Franklin","year":"2020","journal-title":"Comput Inform Nurs."},{"key":"B24","doi-asserted-by":"publisher","first-page":"106815","DOI":"10.1016\/j.ypmed.2021.106815","article-title":"De-implementation of cervical cancer screening before age 21","volume":"153","author":"Silver","year":"2021","journal-title":"Prev Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1097\/GME.0000000000000913","article-title":"Navigating the cervical cancer screening guidelines for women aged older than 65 years","volume":"24","author":"Miller","year":"2017","journal-title":"Menopause."},{"key":"B26","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.jpag.2021.02.097","article-title":"National trends in cervical cancer screening in adolescents","volume":"34","author":"Vash-Margita","year":"2021","journal-title":"J Pediatr Adol Gynec."},{"key":"B27","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.amepre.2017.02.024","article-title":"Cervical cancer screening and incidence by age: unmet needs near and after the stopping age for screening","volume":"53","author":"White","year":"2017","journal-title":"Am J Prev Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/LGT.0000000000000434","article-title":"Should cervical cancer screening be performed before the age of 25 years?","volume":"22","author":"Moscicki","year":"2018","journal-title":"J Low Genit Tract Di."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1353\/hpu.2021.0159","article-title":"Understanding black women's perspectives and experiences of cervical cancer screening: a systematic review and qualitative meta- synthesis","volume":"32","author":"Christy","year":"2021","journal-title":"J Health Care Poor Underserved."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1200\/JCO.22.01424","article-title":"Racial and ethnic disparities in cervical cancer incidence, survival, and mortality by histologic subtype","volume":"41","author":"Cohen","year":"2023","journal-title":"J Clin Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s10552-021-01465-7","article-title":"Financial hardship is associated with lower uptake of colorectal, breast, and cervical cancer screenings","volume":"32","author":"Kasting","year":"2021","journal-title":"Cancer Cause Control."},{"key":"B32","unstructured":"AmericanCancer Society\n          Risk Factors for Cervical Cancer 2023"},{"key":"B33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.nurpra.2015.09.005","article-title":"Cervical cancer screening practices of volunteer providers in faith-based clinics","volume":"12","author":"Denson","year":"2016","journal-title":"Jnp-J Nurse Pract."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e2011645","DOI":"10.1001\/jamanetworkopen.2020.11645","article-title":"Geographic variation in overscreening for colorectal, cervical, and breast cancer among older adults","volume":"3","author":"Moss","year":"2020","journal-title":"JAMA Netw Open"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/jgs.16415","article-title":"Clinician perspectives on overscreening for cancer in older adults with limited life expectancy","volume":"68","author":"Schoenborn","year":"2020","journal-title":"J Am Geriatr Soc."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0174363","DOI":"10.1371\/journal.pone.0174363","article-title":"Determinants of a GP visit and cervical cancer screening examination in Great Britain","volume":"12","author":"Labeit","year":"2017","journal-title":"PLoS ONE"},{"key":"B37","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s00761-021-00932-9","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"27","author":"Alakus","year":"2021","journal-title":"Onkologe."},{"key":"B38","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.pmedr.2015.07.011","article-title":"Adherence to cervical cancer screening varies by human papillomavirus vaccination status in a high-risk population","volume":"2","author":"Paynter","year":"2015","journal-title":"Prev Med Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.canep.2016.04.003","article-title":"Associations between prior HPV4 vaccine doses and cervical cancer screening participation","volume":"42","author":"Boone","year":"2016","journal-title":"Cancer Epidemiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1186\/s12889-016-3397-y","article-title":"How does HPV vaccination status relate to risk perceptions and intention to participate in cervical screening? a survey study","volume":"16","author":"Hestbech","year":"2016","journal-title":"BMC Public Health"},{"key":"B41","unstructured":"HPV Vaccine Information For Young Women: Centers for Diesease Control and Prevention2016"},{"key":"B42","unstructured":"Human Papillomavirus (HPV) Vaccines 2021"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1321253\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T04:41:28Z","timestamp":1713760888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2024.1321253\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":42,"alternative-id":["10.3389\/fpubh.2024.1321253"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2024.1321253","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,22]]},"article-number":"1321253"}}